Literature DB >> 22255880

Chip-scale hermetic feedthroughs for implantable bionics.

Thomas Guenther1, Christopher W D Dodds, Nigel H Lovell, Gregg J Suaning.   

Abstract

Most implantable medical devices such as cochlear implants and visual prostheses require protection of the stimulating electronics. This is achieved by way of a hermetic feedthrough system which typically features three important attributes: biocompatibility with the human body, device hermeticity and density of feedthrough conductors. On the quest for building a visual neuroprosthesis, a high number of stimulating channels is required. This has encouraged new technologies with higher rates of production yield and further miniaturization. An Al(2)O(3) based feedthrough system has been developed comprising up to 20 platinum feedthroughs per square millimeter. Ceramics substrates are shown to have leak rates below 1 × 10(-12) atm × cc/s, thus exceeding the resolution limits of most commercially available leak detectors. A sheet resistance of 0.05 Ω can be achieved. This paper describes the design, fabrication process and hermeticity testing of high density feedthroughs for use in neuroprosthetic implants.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22255880     DOI: 10.1109/IEMBS.2011.6091656

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  3 in total

1.  The development of neural stimulators: a review of preclinical safety and efficacy studies.

Authors:  Robert K Shepherd; Joel Villalobos; Owen Burns; David A X Nayagam
Journal:  J Neural Eng       Date:  2018-05-14       Impact factor: 5.379

2.  3D-Printed Hermetic Alumina Housings.

Authors:  Max Eickenscheidt; Michael Langenmair; Ahmad Dbouk; Dorit Nötzel; Thomas Hanemann; Thomas Stieglitz
Journal:  Materials (Basel)       Date:  2021-01-03       Impact factor: 3.623

Review 3.  Development of implantable medical devices: from an engineering perspective.

Authors:  Yeun-Ho Joung
Journal:  Int Neurourol J       Date:  2013-09-30       Impact factor: 2.835

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.